Premium
Enstilar cutaneous foam for the treatment of psoriasis vulgaris
Author(s) -
Chaplin Steve
Publication year - 2016
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1517
Subject(s) - medicine , calcipotriol , psoriasis , dermatology , betamethasone , plaque psoriasis , adverse effect , betamethasone dipropionate
Enstilar (calcipotriol and betamethasone) is a new cutaneous foam formulation recently launched for the treatment of psoriasis vulgaris (plaque psoriasis) in adults. This article discusses its place in therapy, efficacy and adverse effects.